| scholarly article | Q13442814 |
| P356 | DOI | 10.1155/2014/342693 |
| P8608 | Fatcat ID | release_ndbhawx3tbc5hai2tq55hfp2n4 |
| P932 | PMC publication ID | 4266766 |
| P698 | PubMed publication ID | 25762441 |
| P5875 | ResearchGate publication ID | 273467251 |
| P2093 | author name string | Xiang Cheng | |
| Feng Zhu | |||
| Zhi Li | |||
| Yuanyuan Lv | |||
| Songhai Li | |||
| Qiutang Zeng | |||
| Yuhua Liao | |||
| Wenping Zhou | |||
| Yumiao Wei | |||
| Weijuan Li | |||
| Zihua Zhou | |||
| Yaoqi Chen | |||
| Mengyang Liao | |||
| P2860 | cites work | The human anti-thyroid peroxidase autoantibody repertoire in Graves' and Hashimoto's autoimmune thyroid diseases | Q28205624 |
| Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology | Q28292037 | ||
| The angiotensin II AT1 receptor structure-activity correlations in the light of rhodopsin structure | Q28297667 | ||
| Antibodies against AT1 receptors are associated with vascular endothelial and smooth muscle function impairment: protective effects of hydroxysafflor yellow A | Q28534198 | ||
| Advanced glycation end-products enhance calcification in vascular smooth muscle cells | Q28575353 | ||
| Potential relevance of alpha(1)-adrenergic receptor autoantibodies in refractory hypertension | Q28575913 | ||
| Inflammation, atherosclerosis, and coronary artery disease | Q29547232 | ||
| Signaling to NF-kappaB | Q29547844 | ||
| NAD(P)H oxidase: role in cardiovascular biology and disease | Q29616102 | ||
| Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients | Q29619542 | ||
| Progress and challenges in translating the biology of atherosclerosis | Q29619982 | ||
| Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption | Q30814535 | ||
| Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor | Q33848380 | ||
| Exposure to AT1 receptor autoantibodies during pregnancy increases susceptibility of the maternal heart to postpartum ischemia-reperfusion injury in rats | Q34072217 | ||
| Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy | Q34646571 | ||
| Role of the renin-angiotensin system in vascular inflammation | Q34789029 | ||
| Renin-angiotensin system and atherothrombotic disease: from genes to treatment | Q35136362 | ||
| Activating auto-antibodies against the AT1 receptor in preeclampsia | Q36010629 | ||
| Agonistic AT(1) receptor autoantibody increases in serum of patients with refractory hypertension and improves Ca(2+) mobilization in cultured rat vascular smooth muscle cells | Q36295460 | ||
| Inflammation and cardiovascular disease mechanisms | Q36392615 | ||
| Inflammation and atherosclerosis: novel insights into plaque formation and destabilization | Q36495025 | ||
| Nuclear factor-kappaB as a hormonal intracellular signaling molecule: focus on angiotensin II-induced cardiovascular and renal injury | Q36516285 | ||
| Atherosclerotic plaque stability--what determines the fate of a plaque? | Q37332292 | ||
| Autoimmunity, infectious immunity, and atherosclerosis | Q37606350 | ||
| Crucial role of renin-angiotensin system in the pathogenesis of atherosclerosis | Q37714252 | ||
| NF-κB, inflammation, and metabolic disease. | Q37825008 | ||
| Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy | Q40841949 | ||
| Trans- but not cis-resveratrol impairs angiotensin-II-mediated vascular inflammation through inhibition of NF-κB activation and peroxisome proliferator-activated receptor-gamma upregulation. | Q42937193 | ||
| Autoantibodies against AT1-receptor and alpha1-adrenergic receptor in patients with hypertension | Q44162378 | ||
| AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase | Q44385661 | ||
| Agonistic autoantibodies directed against the angiotensin II AT1 receptor in patients with preeclampsia | Q44413491 | ||
| Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial | Q44783935 | ||
| Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study. | Q44995469 | ||
| Cardiac remodeling after long-term stimulation by antibodies against the alpha1-adrenergic receptor in rats | Q45216646 | ||
| Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection | Q45259438 | ||
| Oxidized low-density lipoprotein-induced proinflammatory cytokine response in macrophages are suppressed by CD4CD25(+)Foxp3(+) regulatory T cells through downregulating toll like receptor 2-mediated activation of NF-kappaB. | Q45303264 | ||
| Arterial structural changes in rats immunized by AT1-receptor peptide | Q46605218 | ||
| Distinct patterns of autoantibodies against G-protein-coupled receptors in Chagas' cardiomyopathy and megacolon. Their potential impact for early risk assessment in asymptomatic Chagas' patients. | Q52905846 | ||
| Is parvovirus B19 the cause for autoimmunity against the angiotensin II type receptor? | Q52928690 | ||
| Th1/Th2 Functional Imbalance After Acute Myocardial Infarction: Coronary Arterial Inflammation or Myocardial Inflammation | Q57524912 | ||
| Functional autoimmune epitope on alpha 1-adrenergic receptors in patients with malignant hypertension | Q71662795 | ||
| Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability | Q73590707 | ||
| AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor | Q73815485 | ||
| Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms | Q73919597 | ||
| Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension | Q74126541 | ||
| Specific removal of beta1-adrenergic autoantibodies from patients with idiopathic dilated cardiomyopathy | Q78587830 | ||
| Functional and structural characterization of anti-beta1-adrenoceptor autoantibodies of spontaneously hypertensive rats | Q79201165 | ||
| Inhibition of IFN regulatory factor-1 down-regulate Th1 cell function in patients with acute coronary syndrome | Q83005979 | ||
| Increased Levels of Soluble Vascular Endothelial Cadherin are Associated with Poor Outcome in Severe Sepsis | Q85166357 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | endothelium | Q111140 |
| acute coronary syndrome | Q266018 | ||
| NF-κB | Q411114 | ||
| autoantibody | Q785022 | ||
| P304 | page(s) | 342693 | |
| P577 | publication date | 2014-11-30 | |
| P1433 | published in | Journal of Immunology Research | Q26841936 |
| P1476 | title | Autoantibodies targeting AT1 receptor from patients with acute coronary syndrome upregulate proinflammatory cytokines expression in endothelial cells involving NF-κB pathway | |
| P478 | volume | 2014 |
| Q39334546 | Anti-calreticulin antibodies and calreticulin in sera of patients diagnosed with dilated or hypertrophic cardiomyopathy. |
| Q90599535 | Autoantibodies against AT1 Receptor Contribute to Vascular Aging and Endothelial Cell Senescence |
| Q55043767 | Cucumis sativus Aqueous Fraction Inhibits Angiotensin II-Induced Inflammation and Oxidative Stress In Vitro. |
| Q91432481 | Dynamic changes in chemosensitivity immune predictors in patients with hypopharyngeal cancer treated with induction chemotherapy |
| Q90365019 | MicroRNA-145 is involved in endothelial cell dysfunction and acts as a promising biomarker of acute coronary syndrome |
| Q37713975 | Reactive oxygen species mediate angiotensin II-induced transcytosis of low-density lipoprotein across endothelial cells. |
| Q38723456 | Role of Inflammation and Immunity in Hypertension: Recent Epidemiological, Laboratory, and Clinical Evidence |
Search more.